Ko‐Chung Lin

885 total citations
13 papers, 736 citations indexed

About

Ko‐Chung Lin is a scholar working on Molecular Biology, Immunology and Allergy and Organic Chemistry. According to data from OpenAlex, Ko‐Chung Lin has authored 13 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Immunology and Allergy and 4 papers in Organic Chemistry. Recurrent topics in Ko‐Chung Lin's work include Cell Adhesion Molecules Research (5 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Biochemical and Structural Characterization (2 papers). Ko‐Chung Lin is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Biochemical and Structural Characterization (2 papers). Ko‐Chung Lin collaborates with scholars based in United States, United Kingdom and Taiwan. Ko‐Chung Lin's co-authors include Alfredo Castro, William H. Pearson, R. Blake Pepinsky, Steven P. Adams, Roy R. Lobb, William M. Abraham, Diane R. Leone, Alan Gill, Ling Ling Chen and Charles E. Hammond and has published in prestigious journals such as Biochemistry, American Journal of Respiratory and Critical Care Medicine and Journal of Medicinal Chemistry.

In The Last Decade

Ko‐Chung Lin

13 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ko‐Chung Lin United States	12	275	258	223	151	134	13	736
Hirokazu Iida Japan	17	339 1.2×	177 0.7×	321 1.4×	96 0.6×	34 0.3×	57	900
Françoise Perron‐Sierra France	14	517 1.9×	333 1.3×	156 0.7×	107 0.7×	88 0.7×	22	925
Gail Van Riper United States	15	422 1.5×	194 0.8×	111 0.5×	508 3.4×	166 1.2×	22	951
Neil Wishart United States	13	231 0.8×	59 0.2×	259 1.2×	207 1.4×	30 0.2×	21	799
R.B. Credo United States	15	334 1.2×	132 0.5×	459 2.1×	75 0.5×	47 0.4×	18	1.3k
Michael A. Dechantsreiter Germany	10	690 2.5×	415 1.6×	345 1.5×	68 0.5×	204 1.5×	12	1.1k
Beth Cooper United States	6	504 1.8×	230 0.9×	142 0.6×	80 0.5×	31 0.2×	6	818
Michael J. LaBarre United States	13	390 1.4×	38 0.1×	69 0.3×	275 1.8×	311 2.3×	27	820
Bohdan Yaremko United States	13	311 1.1×	113 0.4×	130 0.6×	38 0.3×	32 0.2×	19	539
James M. Samanen United States	21	597 2.2×	251 1.0×	347 1.6×	38 0.3×	157 1.2×	34	1.1k

Countries citing papers authored by Ko‐Chung Lin

Since Specialization

Citations

This map shows the geographic impact of Ko‐Chung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko‐Chung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko‐Chung Lin more than expected).

Fields of papers citing papers by Ko‐Chung Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ko‐Chung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko‐Chung Lin. The network helps show where Ko‐Chung Lin may publish in the future.

Co-authorship network of co-authors of Ko‐Chung Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ko‐Chung Lin. A scholar is included among the top collaborators of Ko‐Chung Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko‐Chung Lin. Ko‐Chung Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Huang, Yi‐Wen, Albert Qin, Jane Fang, et al.. (2021). Novel long‐acting ropeginterferon alfa‐2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial. British Journal of Clinical Pharmacology. 88(5). 2396–2407. 18 indexed citations

Bühler, Fritz R., et al.. (2007). The preeminence of clusters. PubMed. 25(11). 1207–9. 1 indexed citations

Vu, Chi B., William F. Kiesman, Patrick R. Conlon, et al.. (2006). Tricyclic Imidazoline Derivatives as Potent and Selective Adenosine A₁Receptor Antagonists. Journal of Medicinal Chemistry. 49(24). 7132–7139. 13 indexed citations

Baker, Darren P., Edward Yin-Shiang Lin, Ko‐Chung Lin, et al.. (2005). N-Terminally PEGylated Human Interferon-β-1a with Improved Pharmacokinetic Properties and in Vivo Efficacy in a Melanoma Angiogenesis Model. Bioconjugate Chemistry. 17(1). 179–188. 117 indexed citations

Koo, Gloria C., Kashmira Shah, G J Ding, et al.. (2003). A Small Molecule Very Late Antigen–4 Antagonist Can Inhibit Ovalbumin-induced Lung Inflammation. American Journal of Respiratory and Critical Care Medicine. 167(10). 1400–1409. 36 indexed citations

Singh, Juswinder, Herman van Vlijmen, Wen‐Cherng Lee, et al.. (2002). 3D QSAR (COMFA) of a series of potent and highly selective VLA-4 antagonists. Journal of Computer-Aided Molecular Design. 16(3). 201–211. 13 indexed citations

Abraham, William M., Alan Gill, Ashfaq Ahmed, et al.. (2000). A Small-Molecule, Tight-binding Inhibitor of the Integrin α4β1 Blocks Antigen-induced Airway Responses and Inflammation in Experimental Asthma in Sheep. American Journal of Respiratory and Critical Care Medicine. 162(2). 603–611. 70 indexed citations

Lin, Ko‐Chung, Lillian T. Chong, Craig Zimmerman, et al.. (1999). Selective, Tight-Binding Inhibitors of Integrin α4β1 That Inhibit Allergic Airway Responses. Journal of Medicinal Chemistry. 42(5). 920–934. 177 indexed citations

Lin, Ko‐Chung & Alfredo Castro. (1998). Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents. Current Opinion in Chemical Biology. 2(4). 453–457. 79 indexed citations

10.

Chen, Ling Ling, Roy R. Lobb, Julio H. Cuervo, et al.. (1998). Identification of Ligand Binding Sites on Integrin α4β1 through Chemical Cross-Linking. Biochemistry. 37(24). 8743–8753. 27 indexed citations

11.

Sikorski, James A., Michael J. Miller, Darryl G. Cleary, et al.. (1993). EPSP Synthase: The Design and Synthesis of Bisubstrate Inhibitors Incorporating Novel 3-Phosphate Mimics. Phosphorus, sulfur, and silicon and the related elements. 76(1-4). 115–118. 115 indexed citations

12.

Miller, Michael J., Karen S. Anderson, Darryl G. Cleary, et al.. (1993). EPSP synthase inhibitor design II. The importance of the 3-phosphate group for ligand binding at the shikimate-3-phosphate site & the identification of 3-malonate ethers as novel 3-phosphate mimics.. Bioorganic & Medicinal Chemistry Letters. 3(7). 1435–1440. 13 indexed citations

13.

Pearson, William H. & Ko‐Chung Lin. (1990). The intramolecular cycloaddition of azides with ω-chloroalkenes. A facile route to (±)-swainsonine and other indolizidine alkaloids. Tetrahedron Letters. 31(52). 7571–7574. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact